Oragenics, Inc. (OGEN)
NYSEAMERICAN: OGEN · IEX Real-Time Price · USD
1.020
0.00 (0.00%)
At close: Jul 19, 2024, 12:00 AM
1.060
+0.040 (3.92%)
Pre-market: Jul 22, 2024, 8:57 AM EDT
Oragenics Employees
Oragenics had 5 employees as of December 31, 2023. The number of employees decreased by 1 or -16.67% compared to the previous year.
Employees
5
Change (1Y)
-1
Growth (1Y)
-16.67%
Revenue / Employee
$4,126
Profits / Employee
-$4,052,347
Market Cap
5.69M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
PolyPid | 62 |
Biomerica | 62 |
Ainos | 46 |
Hepion Pharmaceuticals | 22 |
TFF Pharmaceuticals | 19 |
FSD Pharma | 17 |
Aethlon Medical | 14 |
Sonoma Pharmaceuticals | 10 |
OGEN News
- 25 days ago - Oragenics Develops Automated Intranasal Device for Treating Concussed Patients - GlobeNewsWire
- 25 days ago - Oragenics, Inc. Announces Closing of Public Offering - GlobeNewsWire
- 27 days ago - Oragenics, Inc. Announces Pricing of Public Offering - GlobeNewsWire
- 27 days ago - Oragenics, Inc. Announces Proposed Public Offering - GlobeNewsWire
- 2 months ago - Oragenics Appoints William “Frank” Peacock MD as Chief Clinical Officer - GlobeNewsWire
- 2 months ago - Oragenics, Inc. to Host Webinar Panel on Neurotrauma Medicine - GlobeNewsWire
- 3 months ago - Oragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards - Business Wire
- 4 months ago - Oragenics, Inc. Files 10K and Provides Company Update - Business Wire